VentriPoint Diagnostics (CVE:VPT) Shares Up 3.3% – Should You Buy?

VentriPoint Diagnostics Ltd. (CVE:VPT) shot up 3.3% on Monday . The company traded as high as C$0.16 and last traded at C$0.16. 139,500 shares changed hands during mid-day trading, an increase of 41% from the average session volume of 98,820 shares. The stock had previously closed at C$0.15.

VentriPoint Diagnostics Price Performance

The company has a quick ratio of 6.67, a current ratio of 0.28 and a debt-to-equity ratio of 217.41. The firm has a market capitalization of C$24.36 million, a price-to-earnings ratio of -5.17 and a beta of 0.39. The stock’s 50 day moving average price is C$0.17 and its two-hundred day moving average price is C$0.20.

VentriPoint Diagnostics Company Profile

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.